| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |